Oxford scientists called the bio industry association in february last year, and said, we need your help to scale up our vaccine. And so a coalition of different basi cdm o came together to basically do all,. first the clinical trial manufacture and then the scale up work to actually get it into bulk, industrial scale manufacture. So that's how it all started. And it was all felt pretty hairy at the time, actually. And then we got going, fantastic. That's so interesting. Thank you, kate.
Kate Bingham is the former Chair of the UK Vaccine Taskforce and she's also a shrewd business mind, having been a successful venture capitalist in sectors such as biotech for the past 30 years. She recently spoke with Jessica Pulay at the Cliveden Literary Festival to discuss how business acumen played its part in managing a team of experts from sectors such as science, medicine, industry and academia, in the race to find vaccines to combat the COVID-19 pandemic.
Learn more about your ad choices. Visit podcastchoices.com/adchoices